NYSE: $LLY New Real-World Data on Obesity Management A recent observational study has shed new light on the long-term impact of Zepbound (tirzepatide) on healthcare economics. While the medication is widely recognized for its efficacy in weight management, new data suggests that for adults over the age of 55, it may lead to significant reductions…